Anika Therapeutics, Inc. ANIK Income Statement

Anika therapeutics, inc. (ANIK)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenue
35,397	29,772	29,697	30,418	24,723	26,956	26,787	30,548	21,264	29,388	27,184	33,462	23,386	28,743	25,783	26,575	22,278	25,607	23,676	22,898	15,515	17,880	21,975	21,267	14,351	20,188	17,023	20,067	14,494	21,459	14,055	18,882	13,613	17,725	17,756	15,414	11,060	13,179	13,720
Operating expenses:
Cost of product revenue
14,200	8,649	5,951	6,836	7,311	7,001	8,282	8,152	7,845	8,716	6,250	6,315	6,083	7,539	4,998	6,065	5,425	6,289	5,176	5,275	4,313	5,511	5,724	5,332	4,361	6,234	5,377	6,311	4,841	7,269	7,221	8,084	6,413	7,128	7,394	6,655	5,604	6,108	5,891
Research & development
6,050	4,084	4,158	4,165	4,258	4,064	4,232	4,733	5,161	4,266	5,842	4,449	4,230	2,959	2,822	2,792	2,159	3,016	2,061	1,812	2,098	1,983	1,999	1,873	2,287	2,030	1,618	1,829	1,582	1,339	1,217	1,298	1,533	1,530	1,531	1,574	1,532	1,774	1,836
Selling, general & administrative
14,431	12,237	7,539	7,502	7,672	6,129	5,700	6,417	16,090	6,678	4,823	4,972	5,067	5,488	4,280	4,255	3,990	4,523	3,309	3,388	3,605	3,672	4,044	3,865	3,490	2,399	3,188	3,400	3,947	3,667	3,601	4,108	3,351	4,869	4,712	4,233	4,043	3,908	4,967
Goodwill impairment
18,144	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of contingent consideration
-24,522	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restructuring credits
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	115	196	111	-135	-	-	-	-	-	-	-	-	-	-
Total operating expenses
28,303	24,970	17,648	18,503	19,241	17,194	18,214	19,302	29,096	19,660	16,915	15,736	15,380	15,986	12,100	13,112	11,574	13,828	10,546	10,475	10,016	11,167	11,769	11,071	10,139	10,820	9,988	11,429	10,235	14,814	12,039	13,490	11,297	13,528	13,638	12,463	11,181	11,791	12,695
Income from operations
7,094	4,802	12,049	11,915	5,482	9,762	8,573	11,246	-7,832	9,728	10,269	17,726	8,006	12,740	13,689	13,469	10,709	17,066	13,135	12,429	5,504	12,087	10,286	15,202	23,870	10,430	7,766	9,398	5,011	7,791	2,726	6,133	3,063	4,915	4,817	3,677	556	2,077	1,804
Interest and other income, net
279	360	482	533	498	551	522	290	95	138	261	16	58	49	93	49	72	38	34	24	24	41	9	5	0	-18	-32	-36	-39	-42	-45	-49	-51	-49	-46	-45	-40	-39	-59
Income before income taxes
7,373	5,162	12,531	12,448	5,980	10,313	9,095	11,536	-7,737	9,866	10,530	17,742	8,064	12,789	13,782	13,518	10,781	17,104	13,169	12,453	5,528	12,129	10,296	15,208	23,871	10,412	7,733	9,362	4,971	7,749	2,681	6,084	3,011	4,865	4,771	3,632	515	2,037	1,744
Provision for income taxes
1,580	1,111	3,331	3,013	1,473	2,596	1,496	1,444	-1,051	1,799	3,643	6,373	2,571	4,704	4,830	4,903	3,886	6,061	4,789	4,634	2,012	4,313	4,125	5,906	8,840	3,757	2,776	3,467	1,903	3,286	1,036	2,347	1,099	1,982	1,794	1,349	191	853	678
Net income
5,793	4,051	9,200	9,435	4,507	7,717	7,599	10,092	-6,686	8,067	6,887	11,369	5,493	8,085	8,952	8,615	6,895	11,043	8,380	7,819	3,516	7,815	6,170	9,302	15,030	6,654	4,957	5,894	3,068	4,463	1,645	3,736	1,912	2,883	2,976	2,282	324	1,184	1,066
Net income (in dollars per share)
0.41	0.28	0.65	0.68	0.32	0.54	0.53	0.69	-0.46	0.55	0.47	0.78	0.38	0.56	0.61	0.59	0.46	0.74	0.56	0.52	0.24	0.52	0.42	0.63	1.04	0.43	0.36	0.44	0.23	0.34	0.12	0.28	0.15	0.21	0.23	0.18	0.03	0.09	0.08
Basic weighted average common shares outstanding (in shares)
14,202	14,313	14,070	13,916	14,185	14,200	14,237	14,652	14,679	14,557	14,579	14,588	14,576	14,549	14,625	14,679	14,875	14,903	14,967	14,961	14,905	14,804	14,758	14,687	14,461	15,748	13,682	13,510	13,406	13,330	13,287	13,262	13,162	14,024	12,817	12,725	12,688	12,633	12,645
Diluted net income per share:
Net income (in dollars per share)
0.40	0.27	0.64	0.67	0.31	0.52	0.53	0.68	-0.46	0.52	0.46	0.76	0.37	0.54	0.59	0.57	0.45	0.72	0.55	0.51	0.23	0.54	0.40	0.60	0.97	0.45	0.33	0.40	0.21	0.31	0.11	0.26	0.14	0.21	0.22	0.17	0.02	0.09	0.08
Diluted weighted average common shares outstanding (in shares)
14,353	14,707	14,387	14,088	14,314	14,785	14,377	14,915	14,679	15,070	15,115	15,044	15,043	14,969	15,077	15,111	15,307	15,302	15,316	15,336	15,330	14,648	15,434	15,492	15,499	15,408	14,958	14,578	14,357	14,385	14,459	14,443	14,089	13,741	13,765	13,739	13,744	13,622	13,642
Net income
5,793	4,051	9,200	9,435	4,507	7,717	7,599	10,092	-6,686	8,067	6,887	11,369	5,493	8,085	8,952	8,615	6,895	11,043	8,380	7,819	3,516	7,815	6,170	9,302	15,030	6,654	4,957	5,894	3,068	4,463	1,645	3,736	1,912	2,883	2,976	2,282	324	1,184	1,066
Other comprehensive income:
Unrealized gain (loss) on securities, net of tax
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	-3	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Foreign currency translation adjustment
-129	420	-622	145	-315	-298	-113	-951	620	262	690	1,289	292	-1,218	310	-536	776	-583	258	420	-2,249	-899	-1,679	-190	-26	448	916	340	-749	698	557	-1,600	756	-	-1,576	595	-	-	-
Total other comprehensive income (loss)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	260	417	-	-	-1,679	-190	-	-	916	-	-	-	-	-	-	-	-	-	-	-	-
Comprehensive income
5,664	4,471	8,578	9,580	4,192	7,419	7,486	9,141	-6,066	8,329	7,577	12,658	5,785	6,867	9,262	8,079	7,671	10,461	8,640	8,236	1,267	6,915	4,491	9,111	15,004	7,103	5,873	6,234	2,318	5,161	2,202	2,136	2,668	1,594	1,400	2,877	2,074	4,266	-1,753
Product [Member]
Revenue
35,397	29,767	29,615	30,413	24,717	26,950	26,781	30,542	21,258	28,884	27,178	28,340	23,381	28,279	25,789	26,581	22,283	30,894	23,681	22,904	15,520	23,254	22,055	26,274	34,010	21,251	17,754	20,828	15,247	22,606	14,766	19,624	14,360	18,444	18,455	16,140	11,737	13,869	14,499
Service [Member]
Revenue
-	5	82	5	6	6	6	6	6	504	6	5,122	5	430	6	6	5	5,287	5	6	5	5,374	80	5,007	19,658	1,062	731	760	752	1,147	711	742	747	718	699	726	677	689	778